Best Practices in Pharmacotherapy for Acute Coronary Syndromes
Numerous advances have been made in the therapy of acute coronary syndromes. Despite these advances, acute coronary syndromes still cause significant morbidity and mortality. Decisions as to the best therapy vary depending on other patient factors, such as age, need for chronic anticoagulation, tole...
Saved in:
| Main Author: | Robert Barcelona |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2022-07-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articleindex/usc.2022.05 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CHANGES IN PREHOSPITAL PHARMACOTHERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN 2005-2014 ACCORDING TO THE LIS REGISTER
by: S. Y. Martsevich, et al.
Published: (2015-09-01) -
Advantages of long-term combination pharmacotherapy with a beta-blocker and eplerenone in patients with ST-segment elevation acute coronary syndrome
by: O. A. Osipova, et al.
Published: (2022-07-01) -
ACUTE TONSILLOPHARYNGITIS. RATIONAL PHARMACOTHERAPY
by: D. V. Kharina, et al.
Published: (2013-09-01) -
BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE
by: O. V. Averkov
Published: (2012-06-01) -
Pharmacotherapy of Acute Bronchitis: Setting Priorities
by: A. A. Zaitsev, et al.
Published: (2020-05-01)